Angiotensin II receptor blocker as a novel therapy in acute lung injury induced by avian influenza A H5N1 virus infection in mouse

详细信息    查看全文

• 作者：YiWu Yan (1)
  Qiang Liu (1)
  Ning Li (1)
  JianChao Du (1)
  Xiao Li (2)
  Chang Li (2)
  NingYi Jin (2)
  ChengYu Jiang (1) (3)
  
  1. State Key Laboratory of Medical Molecular Biology ; Institute of Basic Medical Sciences ; Chinese Academy of Medical Sciences ; Department of Biochemistry and Molecular Biology ; Peking Union Medical College ; Tsinghua University ; Beijing ; 100005 ; China
  2. Genetic Engineering Laboratory ; Institute of Military Veterinary ; Academy of Military Medical Sciences ; Changchun ; 130062 ; China
  3. State Key Laboratory of Biotherapy/Collaborative Innovation Center for Biotherapy ; West China Hospital ; Sichuan University ; Chengdu ; 610000 ; China
  
• 刊名：Science China Life Sciences
• 出版年：2015
• 出版时间：February 2015
• 年：2015
• 卷：58
• 期：2
• 页码：208-211
• 全文大小：817 KB
• 参考文献：1. Imai M, Watanabe T, Hatta M, Das SC, Ozawa M, Shinya K, Zhong G, Hanson A, Katsura H, Watanabe S, Li C, Kawakami E, Yamada S, Kiso M, Suzuki Y, Maher EA, Neumann G, Kawaoka Y. Experimental adaptation of an influenza H5 HA confers respiratory droplet transmission to a reassortant H5 HA/H1N1 virus in ferrets. Nature, 2012, 486: 420鈥?28
  2. Herfst S, Schrauwen EJ, Linster M, Chutinimitkul S, de Wit E, Munster VJ, Sorrell EM, Bestebroer TM, Burke DF, Smith DJ, Rimmelzwaan GF, Osterhaus AD, Fouchier RA. Airborne transmission of influenza A/H5N1 virus between ferrets. Science, 2012, 336: 1534鈥?541 CrossRef
  3. Peiris JS, Cheung CY, Leung CY, Nicholls JM. Innate immune responses to influenza A H 5N1: friend or foe? Trends Immunol, 2009, 30: 574鈥?84 CrossRef
  4. Kuba K, Imai Y, Rao S, Gao H, Guo F, Guan B, Huan Y, Yang P, Zhang Y, Deng W, Bao L, Zhang B, Liu G, Wang Z, Chappell M, Liu Y, Zheng D, Leibbrandt A, Wada T, Slutsky AS, Liu D, Qin C, Jiang C, Penninger JM. A crucial role of angiotensin converting enzyme 2 (ACE2) in sars coronavirus-induced lung injury. Nat Med, 2005, 11: 875鈥?79 CrossRef
  5. Zou Z, Yan Y, Shu Y, Gao R, Sun Y, Li X, Ju X, Liang Z, Liu Q, Zhao Y, Guo F, Bai T, Han Z, Zhu J, Zhou H, Huang F, Li C, Lu H, Li N, Li D, Jin N, Penninger JM, Jiang C. Angiotensin-converting enzyme 2 protects from lethal avian influenza A H5N1 infections. Nat Commun, 2014, 5: 3594
  6. Huang F, Guo J, Zou Z, Liu J, Cao B, Zhang S, Li H, Wang W, Sheng M, Liu S, Pan J, Bao C, Zeng M, Xiao H, Qian G, Hu X, Chen Y, Chen Y, Zhao Y, Liu Q, Zhou H, Zhu J, Gao H, Yang S, Liu X, Zheng S, Yang J, Diao H, Cao H, Wu Y, Zhao M, Tan S, Guo D, Zhao X, Ye Y, Wu W, Xu Y, Penninger JM, Li D, Gao GF, Jiang C, Li L. Angiotensin II plasma levels are linked to disease severity and predict fatal outcomes in H7N9-infected patients. Nat Commun, 2014, 5: 3595
  7. Kim S, Iwao H. Molecular and cellular mechanisms of angiotensin II-mediated cardiovascular and renal diseases. Pharmacol Rev, 2000, 52: 11鈥?4
  8. Robles NR, Cerezo I, Hernandez-Gallego R. Renin-angiotensin system blocking drugs. J Cardiovasc Pharmacol Ther, 2014, 19: 14鈥?3 CrossRef
  9. Khan MG. Cardiac Drug Therapy. Springer, 2007
  10. Raiden S, Nahmod K, Nahmod V, Semeniuk G, Pereira Y, Alvarez C, Giordano M, Geffner JR. Nonpeptide antagonists of AT1 receptor for angiotensin II delay the onset of acute respiratory distress syndrome. J Pharmacol Exp Ther, 2002, 303: 45鈥?1 CrossRef
  11. Inada Y, Wada T, Shibouta Y, Ojima M, Sanada T, Ohtsuki K, Itoh K, Kubo K, Kohara Y, Naka T, et al. Antihypertensive effects of a highly potent and long-acting angiotensin II subtype-1 receptor antagonist, (+-)-1-(cyclohexyloxycarbonyloxy)ethyl 2-ethoxy-1-[[2鈥?(1h-tetrazol-5-yl)biphenyl-4-yl]methyl]-1h-benzimidazole-7-carbo-xylate (TCV-116), in various hypertensive rats. J Pharmacol Exp Ther, 1994, 268: 1540鈥?547
  12. Imai Y, Kuba K, Penninger JM. The discovery of angiotensin-converting enzyme 2 and its role in acute lung injury in mice. Exp Physiol, 2008, 93: 543鈥?48 CrossRef
  13. Fedson DS. How will physicians respond to the next influenza pandemic? Clin Infect Dis, 2014, 58: 233鈥?37 CrossRef
  14. Mortensen EM, Nakashima B, Cornell J, Copeland LA, Pugh MJ, Anzueto A, Good C, Restrepo MI, Downs JR, Frei CR, Fine MJ. Population-based study of statins, angiotensin II receptor blockers, and angiotensin-converting enzyme inhibitors on pneumonia-related outcomes. Clin Infect Dis, 2012, 55: 1466鈥?473 CrossRef
  
• 刊物主题：Life Sciences, general;
• 出版者：Springer Berlin Heidelberg
• ISSN：1869-1889

文摘